DR OnQ is developed by NYU Langone Health.

What development phase is DR OnQ in?

DR OnQ is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

DR OnQ

NYU Langone Health · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	DR OnQ
Sponsor	NYU Langone Health
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Single Shot Versus OnQ Pump in Extremity Fractures (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DR OnQ CI brief — competitive landscape report
DR OnQ updates RSS · CI watch RSS
NYU Langone Health portfolio CI